Actuate Therapeutics | 4/A:持股變動聲明(修正)-董事 Bios Equity COF, LP
Actuate Therapeutics | 4/A:持股變動聲明(修正)-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4/A:持股變動聲明(修正)-股東 Kreis Leslie W.
Actuate Therapeutics | SC 13D:超過5%持股股東披露文件-AARON GLENN LOUIS FLETCHER(52.8%),BIOS CAPITAL MANAGEMENT, LP(52.4%)等
Actuate Therapeutics | 4:持股變動聲明-董事 THOMSON TODD S
Actuate Therapeutics | 4:持股變動聲明-董事 Bios Equity COF, LP
Actuate Therapeutics | 4:持股變動聲明-董事 Bios Equity COF, LP
Actuate Therapeutics | 4:持股變動聲明-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4:持股變動聲明-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4:持股變動聲明-股東 Kreis Leslie W.
Actuate Therapeutics | 4:持股變動聲明-股東 Kreis Leslie W.
Actuate Therapeutics | 3:首次持股聲明-董事 Bios 2024 Co-Invest, LP
Actuate Therapeutics | 4:持股變動聲明-董事 Zabrowski Dan
Actuate Therapeutics | 4:持股變動聲明-高管 SCHMITT DANIEL M
Actuate Therapeutics | 4:持股變動聲明-高管 LYTLE PAUL J
Actuate Therapeutics | 4:持股變動聲明-董事 Keyes Jason A
Actuate Therapeutics | 4:持股變動聲明-董事 RONNEBERG AMY L
Actuate Therapeutics | 4:持股變動聲明-董事 Sawhney Roger
Actuate Therapeutics | 3:首次持股聲明-董事 RONNEBERG AMY L
Actuate Therapeutics | 3:首次持股聲明-董事 Sawhney Roger
暫無數據
暫無數據